European Society of Cardiology (ESC)

This page includes news from the European Society of Cardiology (ESC). The ESC represents more than 95,000 men and women in the field of cardiology from Europe, the Mediterranean basin. It is the European umbrella cardiology organization, which includes the European Association of Percutaneous Cardiovascular Interventions (EAPCI), which hosts the large EuroPCR meeting; the European Heart Rhythm Society (EHRA); European Association of Cardiovascular Imaging (EACVI); European Association of Preventive Cardiology (EAPC); and the Association for Acute Cardiovascular Care (ACVC).

RSS icon
birth control the pill cardiovascular disease blood clots side effects

Blood clots much more common among obese women taking combination birth control pills

Progestin-only products may be a "safer alternative" for this patient population, according to a new analysis. 

heart patient

TEER safe and feasible for patients with atrial secondary mitral regurgitation

Atrial secondary mitral regurgitation has been linked to higher in-hospital mortality and hospitalization rates. 

Medtronic EV ICD clinical trial safety endpoints ESC Congress 2022

Medtronic’s first-of-its-kind ICD meets safety endpoints in global clinical trial

The promising results were presented at ESC Congress 2022 and published in the New England Journal of Medicine. Medtronic's new-look device is not yet approved for sale or distribution. 

ESC Congress 2022 European Society of Cardiology

6 key sessions from ESC Congress 2022: TAVR mortality, AI vs. sonographers, radial vs. femoral access and more

ESC Congress 2022, the annual meeting of the European Society of Cardiology, was jam-packed with eye-opening new research from many of the leading voices in cardiovascular and vascular medicine. These six sessions were just some of the weekend's many highlights. 

Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research

Polypill strategy improves odds of survival after a heart attack

The new findings, presented during ESC Congress 2022 and published in the New England Journal of Medicine, suggest that prescribing these new-look pills to heart patients could boost outcomes while also improving medication adherence.

Thumbnail

NSAID use may not be safe for older patients with type 2 diabetes

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022. 

Thumbnail

Medical marijuana linked to a higher risk of heart rhythm issues

The new analysis, presented at ESC Congress 2022, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. 

AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.

VIDEO: Why plaque composition CT imaging may be the future of cardiology

Former European Society of Cardiology president Prof. Jeroen Bax explains the difficulty in quantifying these plaques manually and how artificial intelligence may change this to allow rapid, detailed quantitative analysis. 

Displaying 49 - 56 of 91

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.